10-Q: Avenir Wellness Solutions Reports Q3 2024 Results: Revenue Declines Amid Cost-Cutting Measures

Avenir Wellness Solutions experienced a significant decrease in revenue during the third quarter of 2024, alongside reduced operating expenses and a net loss.

Summary

• Avenir Wellness Solutions reported a net loss of $541,000 for the three months ended September 30, 2024, and a net loss of $2.733 million for the nine months ended September 30, 2024.
• Revenue for the quarter was $192,000, a substantial decrease from $1.011 million in the same period last year, and revenue for the nine months was $919,000, down from $3.221 million in the same period last year.
• The company's operating expenses decreased to $660,000 for the quarter and $2.821 million for the nine months, compared to $2.305 million and $7.156 million respectively in the prior year periods.
• The decrease in revenue is attributed to reduced sales in the Seratopical Revolution, Nutri-Strip, and CBD product lines, as well as the discontinuation of the Power Keto line.
• The company's cash balance stood at $11,000 as of September 30, 2024, with a working capital deficit of $13.1 million.
• Avenir has a going concern warning due to its cash position and accumulated deficit of $126.1 million.

Sentiment

Score: 3

Explanation: The document indicates significant financial challenges, including a substantial revenue decline, a low cash balance, and a going concern warning. While cost-cutting measures are being implemented, the overall outlook is negative.

Positives

• Operating expenses decreased significantly, indicating cost-cutting measures are being implemented.
• The company received $975,000 from the repayment of a note receivable.
• The company has taken steps to remediate material weaknesses in internal controls.

Negatives

• Revenue has decreased substantially across all major product lines.
• The company has a very low cash balance of $11,000 and a significant working capital deficit of $13.1 million.
• Avenir has a going concern warning due to its cash position and accumulated deficit.
• The company has a material weakness in internal controls related to the calculation of earnings per share and segregation of duties.
• The company has outstanding convertible promissory notes with a fair value of $8.713 million, which could potentially convert to shares and dilute existing shareholders.

Risks

• The company's low cash balance and working capital deficit raise substantial doubt about its ability to continue as a going concern.
• The company may need to raise additional capital, but there is no assurance that it will be able to do so on acceptable terms.
• The company's reliance on third-party manufacturers and suppliers exposes it to supply chain disruptions.
• The company's outstanding convertible promissory notes could lead to significant dilution if converted.
• The company's material weakness in internal controls could lead to misstatements in financial reporting.
• Geopolitical conditions and inflation may adversely affect the company's business.

Future Outlook

The company anticipates that it will continue to incur operating losses and negative cash flows from operations as it executes its strategic and business development initiatives. The company plans to use its cash for working capital, product development, and marketing.

Management Comments

• The company's mission is to improve lives by redefining how active ingredients are delivered and experienced.
• The company focuses on evidence-based wellness products that are differentiated by using proprietary and/or proven active ingredients.
• The company anticipates that it will incur decreased operating losses and negative cash flows from operations as it executes on its strategic and business development initiatives and with the elimination of overhead and operating expenses related to the Companys pharmaceutical business segment that have been discontinued in connection with the sale of its pharmaceutical assets.

Industry Context

The company operates in the health, wellness, and beauty sectors, which are experiencing growth. The company's focus on proprietary formulations and technology is intended to differentiate it from competitors. The company's direct-to-consumer sales model is also a common trend in the industry.

Comparison to Industry Standards

• The company's revenue decline is significant compared to industry growth trends in the health and wellness sector.
• The company's low cash balance and working capital deficit are concerning compared to industry benchmarks for companies of similar size.
• The company's reliance on debt financing is higher than industry averages, indicating a higher risk profile.
• The company's material weakness in internal controls is a significant concern compared to industry standards for public companies.
• The company's operating expenses are high relative to its revenue, indicating a need for further cost-cutting measures.

Legal Proceedings

• The company is involved in ongoing litigation with an investor regarding a securities purchase agreement.

Related Party Transactions

• The company has a Senior Secured Promissory Note and Security Agreement with its CEO, Nancy Duitch.
• The company had a distribution services agreement with Advanced Legacy Technologies, LLC, which is beneficially owned by Nancy Duitch, but this agreement was discontinued in 2023.
• The company had a consulting agreement with Rob Davidson, which expired in July 2023.
• The company has been doing business with a third-party contract manufacturer and formulator in which a member of our board of directors acquired a minority interest during the second quarter of 2023.
• The company had a media buying and digital services agreement with an advertising agency of which a member of our board of directors is an officer, but this agreement expired in August 2023.

Stakeholder Impact

• Shareholders are at risk due to the company's low cash balance, going concern warning, and potential dilution from convertible notes.
• Employees may be affected by potential cost-cutting measures or restructuring.
• Customers may be impacted by potential supply chain disruptions or changes in product availability.
• Suppliers may be affected by the company's financial difficulties and potential inability to pay.
• Creditors are at risk due to the company's low cash balance and potential inability to repay debts.

Next Steps

• The company plans to use its cash for working capital, product development, and marketing.
• The company will continue to implement measures to remediate material weaknesses in internal controls.
• The company may need to raise additional capital to continue operations.

Key Dates

Keywords

Avenir Wellness Solutions, Sera Labs, revenue, net loss, operating expenses, cash balance, working capital, convertible notes, internal controls, going concern, nutraceuticals, wellness products, CBD, Seratopical, Nutri-Strips